Dunne takes pot shot at big pharma over cannabis costs

After delegating decisions on medicinal cannabis to the Ministry of Health, Peter Dunne has clarified which products can be prescribed – and made clear they should be prescribed ‘‘with an open mind’’. The list was short, exacerbated by United States export restrictions. Sativex – the only pharmaceutical-grade product available here – ‘‘continues to be extortionately priced as big pharma continues to ignore the building resentment ‘‘to their attitude towards the sick and vulnerable’’.